Bahija Jallal

Bahija Jallal (born May 8, 1961) is chief executive officer and director of the board of Immunocore. She has previously been president at MedImmune and AstraZeneca. She is a council member of the Government–University–Industry Research Roundtable of the National Academies of Sciences, Engineering and Medicine.

Early life and education Jallal grew up in Morocco. She was one of seven children, and her mother raised them alone because her father died at an early age. She became interested in science, first earning doctorate studies in physiology at the Université de Paris VI. She was a postdoctoral researcher in molecular biology and oncology at the Max Planck Institute for Biochemistry.

In 2019 Jallal was appointed chief executive of Immunocore, who focus on T-cell receptors for cellular therapies. Other cellular therapeutic companies were engineering T-cell receptors on T cells ex vivo, Immunocore identified a strategy to use TCRs for soluble biologics.

Awards and honours

2017 Healthcare Businesswomen's Association Woman of the Year 2017 President of the Association of Women in Science

Select publications